Study Details
A study to find the best dose of ASP5354 to show lymph nodes in people with breast cancer or melanoma during surgery
Clinicaltrials.gov ID
Astellas Study ID
5354-CL-1201
EudraCT ID
N/A
Condition
Lymph Node Biopsy, Breast Cancer, Melanoma
Phase
Phase 2
Age
18 Years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Aug 2022 - Sep 2023
Masking
None (Open Label)
Enrollment number
132
A Phase 2 Open-label, Dose-finding Study to Determine the Optimal dose for Lymph Node Visualization using ASP5354 in Participants with Breast Cancer or Melanoma Undergoing Sentinel Lymph Node Biopsy
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to find the best dose of ASP5354 to show lymph nodes in people with breast cancer or melanoma during surgery? Contact us by filling our your information to the right and we’ll respond to you.
Locations
UCI Irvine Health-Chao Family Comprehensive Cancer Center Cancer
Orange, United States, 92868
The University of Texas MD Anderson Cancer Center
Houston, United States, 77030